Literature DB >> 20304159

Ex vivo lung perfusion: early report of Brazilian experience.

P M Pêgo-Fernandes1, I L de Medeiros, A W Mariani, F G Fernandes, F D V Unterpertinger, M N Samano, E D C Werebe, M Canzian, F B Jatene.   

Abstract

INTRODUCTION: Only about 15% of the potential candidates for lung donation are considered suitable for transplantation. A new method for ex vivo lung perfusion (EVLP) can be used to evaluate and recondition "marginal," nonacceptable lungs. We have herein described an initial experience with ex vivo perfusion of 8 donor lungs deemed nonacceptable.
MATERIALS AND METHODS: After harvesting, the lungs were perfused ex vivo with Steen Solution, an extracellular matrix with high colloid osmotic pressure. A membrane oxygenator connected to the circuit received gas from a mixture of nitrogen and carbon dioxide, maintaining a normal mixed venous blood gas level in the perfusate. The lungs were gradually rewarmed, reperfused, and ventilated for evaluation through analyses of oxygenation capacity, pulmonary vascular resistance (PVR), lung compliance (LC), and biopsy.
RESULTS: The arterial oxygen pressure (with inspired oxygen fraction of 100%) increased from a mean of 206 mm Hg in the organ donor at the referring hospital to a mean of 498 mm Hg during the ex vivo evaluation. After 1 hour of EVLP, PVR varied from 440-1454 dynes/sec/cm(5); LC was in the range of 26-90 mL/cmH(2)O. There was no histological deterioration after 10 hours of cold ischemia and 1 hour of EVLP.
CONCLUSIONS: The ex vivo evaluation model can improve oxygenation capacity of "marginal" lungs rejected for transplantation. It has great potential to increase lung donor availability and, possibly, reduce time on the waiting list. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20304159     DOI: 10.1016/j.transproceed.2010.01.015

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

Review 1.  Ex vivo lung perfusion prior to transplantation: an overview of current clinical practice worldwide.

Authors:  Julien Possoz; Arne Neyrinck; Dirk Van Raemdonck
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 2.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

3.  Cell replacement in human lung bioengineering.

Authors:  Brandon A Guenthart; John D O'Neill; Jinho Kim; Kenmond Fung; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Heart Lung Transplant       Date:  2018-11-22       Impact factor: 10.247

Review 4.  Ex vivo lung perfusion review of a revolutionary technology.

Authors:  George Makdisi; Tony Makdisi; Tambi Jarmi; Christiano C Caldeira
Journal:  Ann Transl Med       Date:  2017-09

5.  A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah
Journal:  J Surg Res       Date:  2012-11-27       Impact factor: 2.192

6.  Comparison of lung preservation solutions in human lungs using an ex vivo lung perfusion experimental model.

Authors:  Israel L Medeiros; Paulo M Pêgo-Fernandes; Alessandro W Mariani; Flávio G Fernandes; Fernando V Unterpertinger; Mauro Canzian; Fabio B Jatene
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

7.  Lung transplantation after ex vivo lung perfusion in two Scandinavian centres.

Authors:  Tobias Nilsson; Andreas Wallinder; Ian Henriksen; Jens Christian Nilsson; Sven-Erik Ricksten; Hasse Møller-Sørensen; Gerdt C Riise; Michael Perch; Göran Dellgren
Journal:  Eur J Cardiothorac Surg       Date:  2019-04-01       Impact factor: 4.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.